REQUEST A DEMO
Total
USD $0.00
Search more companies

Bredent Medical d.o.o. (Croatia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Bredent Medical d.o.o. Profile Updated: July 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Bredent Medical d.o.o. is an enterprise in Croatia, with the main office in Zagreb. The enterprise operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was established on December 11, 2025. Bredent Medical d.o.o. currently employs 5 (2023) people. From the latest financial highlights, Bredent Medical d.o.o. reported a net sales revenue increase of 2.84% in 2023. Its total assets grew by 2.57% over the same period. The net profit margin of Bredent Medical d.o.o. increased by 0.57% in 2023.

Headquarters
Zagrebacka Avenija 3 Str.
Zagreb; City of Zagreb; Postal Code: 10000

Contact Details: Purchase the Bredent Medical d.o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Bredent Medical d.o.o. report to view the information.
Financial Auditors:
Purchase the Bredent Medical d.o.o. report to view the information.
Incorporation Date:
December 11, 2025
Key Executives
Purchase this report to view the information.
Manager
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Bredent Medical d.o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency EUR. Absolute financial data is included in the purchased report.
Net sales revenue
2.84%
Total operating revenue
2.84%
Operating profit (EBIT)
52.24%
EBITDA
26.16%
Net Profit (Loss) for the Period
56.46%
Total assets
2.57%
Total equity
39.42%
Operating Profit Margin (ROS)
1.47%
Net Profit Margin
0.57%
Return on Equity (ROE)
-39.94%
Debt to Equity Ratio
-514.77%
Quick Ratio
0.05%
Cash Ratio
-0.06%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?